Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Reps, Jenna; Garibaldi, Jonathan M.; Aickelin, Uwe; Soria, Daniele; Gibson, Jack; Hubbard, Richard (2014)
Publisher: Springer
Languages: English
Types: Article
Subjects: Computer Science - Computational Engineering, Finance, and Science, Computer Science - Learning
The electronic healthcare databases are starting to become more readily available and are thought to have excellent potential for generating adverse drug reaction signals. The Health Improvement Network (THIN) database is an electronic healthcare database containing medical information on over 11 million patients that has excellent potential for detecting ADRs. In this paper we apply four existing electronic healthcare database signal detecting algorithms (MUTARA, HUNT, Temporal Pattern Discovery and modified ROR) on the THIN database for a selection of drugs from six chosen drug families. This is the first comparison of ADR signalling algorithms that includes MUTARA and HUNT and enabled us to set a benchmark for the adverse drug reaction signalling ability of the THIN database. The drugs were selectively chosen to enable a comparison with previous work and for variety. It was found that no algorithm was generally superior and the algorithms’ natural thresholds act at variable stringencies. Furthermore, none of the algorithms perform well at detecting rare ADRs.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Almeno , J., Tonning, J.M., Gould, A.L., et al: Perspectives on the use of data mining in pharmacovigilance. Drug Saf 28(11), 981{1007 (2005)
    • 2. Alvarez-Requejo, A., Carvajal, A., Begaud, B., et al: Under-reporting of adverse drug reactions- estimate based on a spontaneous reporting scheme and a sentinel system. Eur J Clin Pharmacol 54(6), 483{488 (1998)
    • 3. Bate, A., Lindquist, M., Edwards, I.R., et al: A bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 54, 315{321 (1998)
    • 4. Behrman, R.E., Benner, J.S., Brown, J.S., et al: Developing the sentinel system - a national resource for evidence development. N Engl J Med 364, 498{499 (2011)
    • 5. Brown, J.S., Kulldor , M., Chan, A., et al: Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf 16, 1275{1284 (2007)
    • 6. Coloma, P.M., Schuemie, M.J., Tri ro, G., et al: Combining electronic healthcare databases in europe to allow for large-scale drug safety monitoring: the eu-adr project. Pharmacoepidemiol Drug Saf 20, 1{11 (2011)
    • 7. Curtis, J.R., Cheng, H., Delzell, E., et al: Adaptation of bayesian data mining algorithms to longitudinal claims data: coxib safety as an example. Med Care 46, 969{975 (2008)
    • 8. DuMouchel, W.: Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting systemt. Amer Statistician 53(3), 177{190 (1999)
    • 9. Evans, S.J.W., Waller, P.C., Davis, S.: Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol and Drug Saf 10(6), 483{486 (2001)
    • 10. INPS, A Cegedim Company: Welcome to inps, http://www.inps4.co.uk/ (2011, accessed 25 jan 2012)
    • 11. Jin, H., Chen, J., Kelman, C., et al: Mining unexpected associations for signalling potential adverse drug reactions from administrative health databases. PAKDD pp. 867{876 (2006)
    • 12. Jin, H.W., Chen, J., He, H., et al: Signaling potential adverse drug reactions from administrative health databases. IEEE Trans Knowl Data Eng 22(6), 839{ 853 (2010)
    • 13. Joint Formulary Committee . British National Formulary: 62 ed. London: BMJ Group and Pharmaceutical Press (2011)
    • 14. Lewis, J.D., Bilker, W.B., Weinstein, R.B., Strom, B.L.: The relationship between time since registration and measured incidence rates in the general practice research database. Pharmacoepidemiol Drug Saf 14(7), 443{451 (2005)
    • 15. Noren, G.N., Hopstadius, J., Bate, A., et al: Temporal pattern discovery in longitudinal electronic patients records. Data Min Knowl Disc 20, 361{387 (2010)
    • 16. Piromohamed, M., James, S., Meakin, S., et al: Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. Br Med J 329, 15{19 (2004)
    • 17. van Puijenbroek, E.P., Bate, A., Leufkens, H.G.M., et al: A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 11(1), 3{ 10 (2002)
    • 18. Rosenberg, L., Coogan, P., Palmer, J.: Case-Control Surveillance, in Pharmacoepidemiology, fourth edition (ed b. l. strom) edn. John Wiley & Sons, Chichester, UK (2007)
    • 19. Ryan, P.B., Madigan, D., Stang, P.E., Overhage, J.M., Racoosin, J.A., G.Hartzema, A.: Empirical assessment of methods for risk identi cation in healthcare data: Results from the experiments of the observational medical outcomes partnership. Statist. Med. 31, 4401{4415 (2012)
    • 20. Ryan, P.B., Powell, G., Pattishall, E., Beach, K.: Performance of screening multiple observational databases for active drug safety surveillance. International Society of Pharmacoepidermiology:Providence,RI,USA, (2009)
    • 21. Schuemie, M.J., Coloma, P.M., Straatman, H., Herings, R.M.C., Tri r, G., Matthews, J.N., Prieto-Merino, D., Molokhia, M., Gini, L.P.R., Innocent, F., Mazzaglia, G., Picelli, G., Scotti, L., van der Lei, J., Sturkenboom, M.C.J.M.: Using electronic health care records for drug safety signal detection: A comparative evaluation of statistical methods. Medical Care. 50(10, 890{897 (2012)
    • 22. Shephard, E., Stapley, S., Hamilton, W.: The use of electronic databases in primary care research. Fam Pract 28(4), 352{354 (2011). DOI 10.1093/fampra/cmr039
    • 23. Story, N.L.: Sexual dysfunction resulting from drug side e ects. J Sex Res 10(2), 132{149 (1974)
    • 24. WHO Collaborating Centre for Drug Statistics Methodology: ATC classi cation index with DDDs, 2013. Oslo (2012)
    • 25. Wilke, R.A., Xu, H., Denny, J.C., et al: The emerging role of electronic medical records in pharmacogenomics. Int J Clin Pharmacol Ther 89(3), 379{386 (2001)
    • 26. World Health Organization: International Statistical Classi cation of Diseases and Related Health Problems (The) ICD-10. 2010 Edition. Nonserial Publications (2011)
    • 27. Zhou, X., Murugesan, S., Bhullar, H., Liu, Q., Cai, B., Wentworth, C., Bate, A.: An evaluation of the thin database in the omop common data model for active drug safety surveillance. Drug Saf 36, 119{134 (2013)
    • 28. Zorych, I., Madigan, D., Ryan, P., et al: Disproportionality methods for pharmacovigilance in longitudinal observational databases. Stat Methods Med Res 0(0), 1{18 (2011)
  • No related research data.
  • Discovered through pilot similarity algorithms. Send us your feedback.

Share - Bookmark

Cite this article